ストックスクリーナーアプリを入手
8.26
6.24%
-0.55
アフターアワーズ：
8.44
0.18
+2.18%
前日終値:
$8.81
開ける：
$8.81
24時間の取引高:
71,655
Relative Volume:
0.42
時価総額：
$8.24M
収益：
$12.99M
当期純損益:
$-23.72M
株価収益率:
-0.0849
EPS:
-97.2514
ネットキャッシュフロー:
$-23.28M
1週間 パフォーマンス:
-15.97%
1か月 パフォーマンス:
-24.41%
6か月 パフォーマンス:
-85.00%
1年 パフォーマンス:
-99.49%
1日の値動き範囲:
$8.14
$8.8101
1週間の範囲:
$8.14
$9.97
52週間の値動き範囲:
$7.66
$1,688.40
Aptevo Therapeutics Inc Stock (APVO) Company Profile
APVO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
8.26 | 8.79M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2018-11-05 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-10-05 | 再開されました | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc (APVO) 最新ニュース
Growth Report: Can Compass Minerals International Inc. deliver consistent EPS growthInsider Selling & Community Verified Swing Trade Signals - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Take Profit: Is Weave Communications Inc a defensive stock2025 Analyst Calls & Accurate Intraday Trading Signals - baoquankhu1.vn
VIX Spike: What are Aptevo Therapeutics Incs recent SEC filings showingTrade Exit Report & Fast Moving Market Watchlists - baoquankhu1.vn
Chipmakers Recap: Is NTNX stock overvalued or fairly priced2025 Buyback Activity & Reliable Price Action Trade Plans - baoquankhu1.vn
Aptevo Therapeutics (NASDAQ: APVO) seeks OK for $60M SEPA share sales - Stock Titan
APVO Stock Price, Forecast & Analysis | APTEVO THERAPEUTICS INC (NASDAQ:APVO) - Chartmill
Income Plays: Does Eastman Kodak Company align with a passive investing strategy - baoquankhu1.vn
Market Overview: How sensitive is HUHUTECH International Group Inc to inflationJuly 2025 Movers & Verified Momentum Stock Watchlist - baoquankhu1.vn
Aptevo Therapeutics (APVO) Price Target Increased by 1,700.00% to 7,711.20 - Nasdaq
Market Fear: Is Aptevo Therapeutics Inc stock trending bullishWeekly Trading Summary & Consistent Growth Stock Picks - baoquankhu1.vn
HOKA Size Guide: What valuation multiples suggest for Aptevo Therapeutics Inc. stockNew Releases Roundup & road comfort picks for daily use - Улправда
Aptevo Therapeutics Secures $60 Million Equity Financing Facility - The Globe and Mail
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aptevo Therapeutics shares jump after $60 million equity facility secured - MSN
Aptevo Therapeutics stock jumps after securing $60 million equity line By Investing.com - Investing.com South Africa
Aptevo Therapeutics stock jumps after securing $60 million equity line - Investing.com
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality - The Globe and Mail
Aptevo secures $60 million equity line of credit to fund operations - Investing.com Nigeria
Aptevo Therapeutics (APVO) Secures $60 Million Equity Line - GuruFocus
Aptevo Therapeutics enters equity purchase agreement with YA II PN, Ltd - marketscreener.com
Aptevo Therapeutics Signs Standby Equity Purchase Agreement With Yorkville - TradingView — Track All Markets
Biotech lines up $60M to keep next-wave cancer drugs moving to 2029 - Stock Titan
What valuation multiples suggest for Aptevo Therapeutics Inc. stockNew Releases Roundup & road comfort picks for daily use - Улправда
Will Aptevo Therapeutics Inc. (AP81) stock maintain strong growthWeekly Stock Recap & Community Supported Trade Ideas - Улправда
Will Aptevo Therapeutics Inc. stock deliver shareholder valueEarnings Risk Report & Low Risk High Reward Trade Ideas - Улправда
Will Aptevo Therapeutics Inc. stock continue upward momentum2025 Top Decliners & Fast Momentum Entry Tips - Улправда
Is Aptevo Therapeutics Inc. stock a smart buy before Fed meetingPortfolio Performance Summary & Free Verified High Yield Trade Plans - Улправда
Quarterly Trades: What consensus target says about Aptevo Therapeutics Inc. (AP81) stockCEO Change & Risk Controlled Daily Trade Plans - Улправда
Is Aptevo Therapeutics Inc. stock a buy for dividend growthRisk Management & Technical Confirmation Trade Alerts - Улправда
Quarterly Recap: Will Aptevo Therapeutics Inc stock continue upward momentumAnalyst Downgrade & Growth Oriented Trade Recommendations - Bộ Nội Vụ
Aptevo Therapeutics announces 1-for-18 reverse stock split - MSN
Aptevo Therapeutics (APVO) Stock Price, Quote, News & History - Benzinga
Aptevo Therapeutics enacts 1-for-18 reverse stock split, shares to trade on split-adjusted basis - Investing.com Australia
Aptevo Therapeutics enacts 1-for-18 reverse stock split, shares to trade on split-adjusted basis By Investing.com - Investing.com Australia
Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split - TipRanks
Aptevo Therapeutics To Implement 1-for-18 Reverse Stock Split - Nasdaq
Aptevo Therapeutics Inc. (APVO) Stock: Plummets 36% Ahead of 1-for-18 Reverse Split - parameter.io
Aptevo Therapeutics to implement 1-for-18 reverse stock split By Investing.com - Investing.com Australia
Aptevo Therapeutics Stock Slumps To All-Time Low On Reverse Split Approval - Asianet Newsable
Why Aptevo Therapeutics Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Benzinga
Aptevo Therapeutics (APVO) Announces 1-for-18 Reverse Stock Spli - GuruFocus
Aptevo Therapeutics stock slumps to all-time low on reverse split approval - MSN
Aptevo Therapeutics Inc (APVO) 財務データ
収益
当期純利益
現金流量
EPS
2.09%
0.48%
大文字化:
|
ボリューム (24 時間):